New scan aims to uncover hidden breast cancer in early stage patients

NCT ID NCT06540872

Recruiting now Diagnosis Sponsor: Universität Münster Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new imaging method called FAPI-PET/MRI to see if it can detect hidden invasive breast cancer in 30 people diagnosed with ductal carcinoma in situ (DCIS), a common pre-stage of breast cancer. Participants receive a weakly radioactive drug and lie in a scanner for about 45 minutes. The results will be compared to tissue samples from surgery to see how accurate the scan is.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, INTRADUCTAL, NONINFILTRATING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast neoplasm ductal breast carcinoma in situ

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARCINOMA, INTRADUCTAL, NONINFILTRATING

Contacts and locations

Locations

Department of Nuclear Medicine, University Hospital Essen
NOT_YET_RECRUITING

Essen, North Rhine-Westphalia, 45147, Germany
Department of Nuclear Medicine, University Hospital Münster
RECRUITING

Münster, North Rhine-Westphalia, 48149, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.